✦ LIBER ✦

P1.203 Immediate vs. delayed-start pramipexole in early Parkinson's disease: the PROUD study

✍ Scribed by A. Schapira; S. Albrecht; P. Barone; C. Comella; H. Hsu; D. Massey; M. McDermott; W. Poewe; O. Rascol; K. Scrine; K. Marek

Book ID: 117753528
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 64 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(09)70325-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for delayed-start study of pra

Rationale for delayed-start study of pramipexole in Parkinson's disease: The PROUD study

✍ Anthony H.V. Schapira; Stefan Albrecht; Paolo Barone; Cynthia L. Comella; Michae 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract Perhaps the most important unmet need in Parkinson's disease (PD) is the ability to slow or prevent progression of the neurodegeneration that underlies the motor and nonmotor features of this disorder. Pramipexole, a dopamine agonist used for the symptomatic treatment of PD, has demonst

Pramipexole in patients with early Parki

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

✍ Schapira, Anthony HV; McDermott, Michael P; Barone, Paolo; Comella, Cynthia L; A 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 235 KB

PROUD stands tall: delayed-start studies

PROUD stands tall: delayed-start studies in Parkinson's disease

✍ Hauser, Robert A 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 49 KB

P2.155 Simple overnight switching from i

P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage

✍ O. Rascol; P. Barone; R. Hauser; Y. Mizuno; W. Poewe; A. Schapira; C. Debieuvre; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

Twice-daily, low-dose pramipexole in ear

Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial

✍ Karl Kieburtz; The Parkinson Study Group PramiBID Investigators 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, double‐blind, placebo controlled trial involving 311 early PD patients not receiving dopaminer